Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1325 of 3173 entries
View as:

Safety And Efficacy Of Bosutinib

Phase: N/A Priority: Normal
NCT ID: NCT02501330 Org: User:
Start: 07/01/15 End: 02/28/24 Due: 02/28/25

A Study To Assess Absorption Of Study Drug Dacomitinib (PF-00299804), Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01796327 Org: User:
Start: 04/30/13 End: 06/30/13 Due: 06/30/14

A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01405157 Org: User:
Start: 01/01/12 End: 02/20/12 Due: 02/20/13

A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Oral Doses Of PF-06273340

Phase: N/A Priority: Normal
NCT ID: NCT01601834 Org: User:
Start: 05/31/12 End: 06/30/12 Due: 06/30/13

Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01475461 Org: User:
Start: 11/30/11 End: 01/31/13 Due: 01/31/14

Anidulafungin In Treatment Of Candidemia In Asian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00537329 Org: User:
Start: 01/31/08 End: 03/31/09 Due: 03/31/10

Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT00002010 Org: User:
Start: - End: - Due: -

A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT00886093 Org: User:
Start: 04/30/09 End: 05/31/09 Due: 05/31/10

Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00848354 Org: User:
Start: 06/30/09 End: 04/30/13 Due: 04/30/14

Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01521884 Org: User:
Start: 11/30/10 End: 02/28/14 Due: 02/28/15

Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate

Phase: N/A Priority: Normal
NCT ID: NCT02142868 Org: User:
Start: - End: - Due: -

A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste

Phase: N/A Priority: Normal
NCT ID: NCT00762151 Org: User:
Start: 11/30/07 End: 01/31/08 Due: 01/31/09

Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection

Phase: N/A Priority: Normal
NCT ID: NCT04927312 Org: User:
Start: 10/01/21 End: 09/15/22 Due: 09/15/23

An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00143325 Org: User:
Start: 01/31/05 End: 06/30/06 Due: 06/30/07

A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1

Phase: N/A Priority: Normal
NCT ID: NCT00824421 Org: User:
Start: 02/28/09 End: 10/31/11 Due: 10/31/12

Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04424303 Org: User:
Start: 12/04/20 End: 06/30/26 Due: 06/30/27

IGF1 Generation Test

Phase: N/A Priority: Normal
NCT ID: NCT00145457 Org: User:
Start: 04/30/01 End: 01/31/05 Due: 01/31/06

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02224664 Org: User:
Start: 10/31/14 End: 03/31/16 Due: 03/31/17

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Phase: N/A Priority: Normal
NCT ID: NCT05375955 Org: User:
Start: 09/26/22 End: 07/31/23 Due: 07/31/24

Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan

Phase: N/A Priority: Normal
NCT ID: NCT00661661 Org: User:
Start: 04/30/08 End: 12/31/13 Due: 12/31/14

A Study to Assess the Levels of Two Antibiotics in the Blood When Given Together and Separately

Phase: N/A Priority: Normal
NCT ID: NCT01430910 Org: User:
Start: 09/30/11 End: 10/31/12 Due: 10/31/13

Varenicline Observational Investigation In The Cessation of Smoking

Phase: N/A Priority: Normal
NCT ID: NCT00669240 Org: User:
Start: 11/30/07 End: 08/31/09 Due: 08/31/10

Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

Phase: N/A Priority: Normal
NCT ID: NCT05399329 Org: User:
Start: 04/20/22 End: 05/31/25 Due: 05/31/26

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

Phase: N/A Priority: Normal
NCT ID: NCT00443534 Org: User:
Start: 05/31/06 End: 12/31/11 Due: 12/31/12

A Study to Investigate the Effect of ICA-105665 in Photosensitive Epilepsy Patients

Phase: N/A Priority: Normal
NCT ID: NCT00979004 Org: User:
Start: 09/30/09 End: 09/30/10 Due: 09/30/11